rhodioloside has been researched along with Carcinoma, Lewis Lung in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cui, L; Li, P; Wen, Z; Yue, Q; Zhang, M; Zhang, X; Zhang, Y | 1 |
Huang, R; Wang, Y; Wang, Z; Xiao, W; Xiao, Y; Yan, J; Yang, R; Zhang, X; Zheng, C; Zhou, J; Zhu, J | 1 |
2 other study(ies) available for rhodioloside and Carcinoma, Lewis Lung
Article | Year |
---|---|
[Salidroside induces anti-tumor effect in dendritic cells via ERK pathway].
Topics: Animals; Carcinoma, Lewis Lung; Cells, Cultured; Dendritic Cells; Glucosides; Interleukin-12; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Phenols; T-Lymphocytes, Cytotoxic | 2019 |
Systems pharmacology unravels the synergic target space and therapeutic potential of Rhodiola rosea L. for non-small cell lung cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Availability; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Drug Screening Assays, Antitumor; Flavonoids; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Monosaccharides; Phenols; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-bcl-2; RAW 264.7 Cells; Rhodiola; Signal Transduction; Transcription Factor RelA | 2020 |